MedTrace Logo

Determination of Residual Anticoagulatory Effects of Fondaparinux

NCT01101256 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2010-04-13

No results posted yet for this study

Summary

The purpose of this study is to determine residual anticoagulatory effects of a prophylactic or therapeutic fondaparinux treatment i.e. prior to surgery/intervention, after pause of therapy etc.

Conditions

  • Anticoagulant Prophylaxis/Therapy

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Marc Schindewolf, MD · J.W. Goethe University Hospital Frankfurt/M.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-09-30
Completion
2010-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101256 on ClinicalTrials.gov